Journal
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
Volume 118, Issue -, Pages 775-783Publisher
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.neubiorev.2020.09.011
Keywords
Wfs1; Wolframin; Wfs2; Cisd2; Wolfram Syndrome; ER stress; Unfolded protein response; Mitochondria; Mitophagy; Excitotoxicity
Categories
Funding
- National Institutes of Health [AG056673]
- Department of Defense [W81XWH1910309]
- Alzheimer's Association [AARF-17-505009]
- Neuroscience Research Institute Pilot Award
- Ohio State University
- U.S. Department of Defense (DOD) [W81XWH1910309] Funding Source: U.S. Department of Defense (DOD)
Ask authors/readers for more resources
L.P. Li, L. Venkataraman, S. Chen, and H.J. Fu. Function of WFS1 and WFS2 in the Central Nervous System: Implications for Wolfram Syndrome and Alzheimer's Disease. NEUROSCI BIOBEHAV REVXXX-XXX,2020.Wolfram syndrome (WS) is a rare monogenetic spectrum disorder characterized by insulin-dependent juvenile-onset diabetes mellitus, diabetes insipidus, optic nerve atrophy, hearing loss, progressive neurodegeneration, and a wide spectrum of psychiatric manifestations. Most WS patients belong to Wolfram Syndrome type 1 (WS1) caused by mutations in the Wolfram Syndrome 1 (WFS1/Wolframin) gene, while a small fraction of patients belongs to Wolfram Syndrome type 2 (WS2) caused by pathogenic variants in the CDGSH Iron Sulfur Domain 2 (CISD2/WFS2) gene. Although currently there is no treatment for this life-threatening disease, the molecular mechanisms underlying the pathogenesis of WS have been proposed. Interestingly, Alzheimer's disease (AD), an age-dependent neurodegenerative disease, shares some common mechanisms with WS. In this review, we focus on the function of WFS1 and WFS2 in the central nervous system as well as their implications in WS and AD. We also propose three future directions for elucidating the role of WFS1 and WFS2 in WS and AD.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available